In March 2011, the high standard edaravone raw materials and injection developed by C&O was approved by SFDA. Edaravone is a neuroprotective agent, used to improve neurological symptoms, activities of daily living and functional impairment due to acute cerebral infarction.
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mail[email protected]
Official WeChat account Mobile page